Tectorigenin protects cell damage in Parkinson's disease model by regulating miR-103a-3p/SHC3 pathway
Objective To investigate the effect of tectorigenin on cell model of Parkinson's disease (PD), so as to further analyze whether its mechanism is related to the regulation of miR-103a-3p/SHC adaptor protein 3 (SHC3) pathway. Methods PC12 cells were treated with 250 mmol/L 1-methyl-4-phenylpyridi...
Main Authors: | LI Qian, FU Zijuan, SUN Peng, CAO Yibin |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Journal of Third Military Medical University
2021-12-01
|
Series: | Di-san junyi daxue xuebao |
Subjects: | |
Online Access: | http://aammt.tmmu.edu.cn/Upload/rhtml/202106021.htm |
Similar Items
-
Tectorigenin: A Review of Its Sources, Pharmacology, Toxicity, and Pharmacokinetics
by: Juan Rong, et al.
Published: (2023-08-01) -
The Long Non-Coding RNA AC006329.1 Facilitates Hepatocellular Carcinoma Progression and Metastasis by Regulating miR-127-5p/SHC3/ERK Axis
by: Kong XX, et al.
Published: (2023-07-01) -
Expressions of miR-96 and miR-103 in Hepatocellular Carcinoma and Their Correlation with Prognosis
by: XIAO Wei, et al.
Published: (2020-06-01) -
Anti-inflammatory and anti-osteoarthritis effects of tectorigenin
by: Cheng-Long Wang, et al.
Published: (2017-08-01) -
Exploring the Gut–Mitochondrial Axis: p66Shc Adapter Protein and Its Implications for Metabolic Disorders
by: Ana Clara da C. Pinaffi-Langley, et al.
Published: (2024-03-01)